X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Titan Krios G4 – A Biomed Research Advancement In Australia

Content Team by Content Team
14th June 2024
in News
Titan Krios G4 – A Biomed Research Advancement In Australia

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

In May 2024, the Ramaciotti Centre for Cryo-Electron Microscopy went on to launch the Titan Krios G4 microscope, a state-of-the-art instrument that happens to be one of the most advanced microscopes from Australia.

It is well to be noted that microscopy happens to be a basic technique when it comes to biomedical research, and the record-breaking resolutions that the Titan Krios G4 brings will go on to enable the researchers to dig deeper into the molecular bodies as far as human bodies are concerned, thereby offering critical insights in terms of the prevention of diseases, their management, as well as cure.

Funded by Microscopy Australia as well as enabled by the National Collaborative Research Infrastructure Strategy- NCRIS, Monash Australia, along with the Victorian Higher Education State Investment Fund- VHESIF, the Titan Krios G4 happens to be an exceptional addition in terms of Australian national microscopy capacity.

The Titan Krios G4, which has been developed by Thermo Fisher Scientific, has gone on to achieve record breaking resolutions when it comes to biological imaging, and it is indeed going to be offering a prominent step-change in the country’s capacity to go ahead and perform cryo-electron tomography, a technique that happens to bridge the gap between cells as well as structural biology with high-resolution.

In case combined with the subtomogram averaging, it enables the determination of molecular structures wherein they sit inside the cell. Apart from this, the Krios is going to be offering an uplift in capacity for single-particle evaluation and also raise capacity in terms of emerging techniques like microcrystal electron diffraction.

The fact is that Australian researchers can now very effectively compete with researchers from overseas and make use of cryo-EM as well as cryo-ET so as to see biological samples at a near atomic resolution, hence driving advances when it comes to biomedicine.

At present, the most intensive users when it comes to the new Krios G4 and also the previous generation Krios K1 happen to be the leading experts from the world at Monash Biomedicine Discovery Institute. Notably, their usage of Krios platforms is going to continue to underpin explorations within infectious diseases, cancer, heart diseases, antibiotic resistance, and also neurological diseases.

Georg Ramm, the Associate Professor and Director at the Ramaciotti Centre for Cryo-EM and also the Lab Head at the Monash BDI, is going to be making use of the instrument as part of the Chan Zuckerberg Initiative imaging scientist grant that he has received. Significantly, the project looks to create workflows in terms of cryo-tomography within tissues so that the researchers can as well study the tissues’ molecular architecture in disease and health.

He is going to be working directly with the collaborators so as to use cryo-tomography in order to answer fundamental biomedical questions as well as teach new techniques to cell as well as structural biologists. The Titan Krios G4 launch happens to represent a leap ahead in the capabilities to reveal the basic building blocks of the body, the acumen that is indeed necessary for driving medical research along with innovation in Australia.

Previous Post

Hepatitis Screening in Community Pharmacies as a Measure of Reducing the Rate of Infections

Next Post

Australia Biomedical Space Drives World Innovation, Research

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

Australia Biomedical Space Drives World Innovation, Research

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In